Home > National Drug Code (NDC) > Diamox Sequels

Diamox Sequels - 52125-070-02 - (Acetazolamide)

Alphabetical Index


Drug Information of Diamox Sequels

Product NDC: 52125-070
Proprietary Name: Diamox Sequels
Non Proprietary Name: Acetazolamide
Active Ingredient(s): 500    mg/1 & nbsp;   Acetazolamide
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Diamox Sequels

Product NDC: 52125-070
Labeler Name: REMEDYREPACK INC.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA012945
Marketing Category: NDA
Start Marketing Date: 20130221

Package Information of Diamox Sequels

Package NDC: 52125-070-02
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (52125-070-02)

NDC Information of Diamox Sequels

NDC Code 52125-070-02
Proprietary Name Diamox Sequels
Package Description 30 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (52125-070-02)
Product NDC 52125-070
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Acetazolamide
Dosage Form Name CAPSULE, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20130221
Marketing Category Name NDA
Labeler Name REMEDYREPACK INC.
Substance Name ACETAZOLAMIDE
Strength Number 500
Strength Unit mg/1
Pharmaceutical Classes Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [Chemical/Ingredient]

Complete Information of Diamox Sequels


General Information